Director, Medical Affairs Oncology, Strategic Evidence & Collaborations (SEC)

Role: Director, Medical Affairs Oncology, Strategic Evidence & Collaborations (SEC)
Remote; quarterly headquarters travel. Must be able to travel >50% (domestic and international).

Responsibilities:
- Co-develop US Medical Affairs strategy for congress plans with COE and USMA Strategy/Field Based Medical Teams.
- Establish and execute evidence-generation strategy across tumor types in the US, including cooperative groups and NCI/CTEP.
- Provide input to US and Global Medical Affairs Strategic Plans for ADC portfolio (incl. Integrated Strategic Plan) and to US/Global Medical Plan of Action (POA).
- Provide medical/scientific leadership for US HCP/patient-facing meetings; support global/regional congress planning and execution.
- Lead/coordinate US Medical efforts for US oncology societies.
- Serve as an information resource (incl. educational activities, grants, investigator-sponsored/collaborative studies).
- Collaborate on Investigator Sponsored Research with Medical Affairs Research and Clinical R&D; review study proposals/abstracts/manuscripts; support publication strategy.
- On occasion, lead compliant fair-balanced scientific presentations and participate in editorial review.

Basic Qualifications:
- Advanced degree (PhD/MD/PharmD) + 8+ years Medical Affairs, OR MA/MS + 10+ years, OR BA/BS + 12+ years.

Preferred Qualifications:
- 10+ years Medical Affairs; oncology experience.
- Strategic thinking with actionable plans; strong written/verbal/interpersonal/negotiation/communication.
- Strong organizational, teamwork, attention to detail, analytical/problem-solving.
- FDA/ICH/GCP knowledge preferred; autonomy.

Benefits:
- Eligible for discretionary bonus/LTI, paid time off, and company-sponsored medical/dental/vision/life insurance.

Application instructions:
- For current Gilead employees/contractors: apply via the Internal Career Opportunities portal in Workday.